Eric Gamazon Archives
Study links genetic variants, protein expression and human diseases
Oct. 21, 2021—An international research team has developed a new resource that connects genetic variants and protein expression, which is expected to speed the identification of genes that cause disease — and point to novel treatment strategies.
Genetics of hydrocephalus
Jul. 8, 2021—Fluid build-up in the brain — hydrocephalus — increases pressure and risk for brain damage; Vanderbilt researchers have now identified genes and signaling pathways associated with the condition.
New tool to probe genetic mechanisms of disease
Oct. 22, 2020—Vanderbilt Genetics Institute investigators have added a new method to the computational genetics toolbox. Their approach, described in the journal Nature Genetics, integrates vast genomics datasets to predict gene expression and facilitate discovery of genetic mechanisms underlying human diseases.
Award supports integration of genomic data, electronic health records
Sep. 10, 2020—Eric Gamazon, PhD, assistant professor of Medicine, has been awarded a $1.5 million grant from the National Human Genome Research Institute, part of the National Institutes of Health (NIH), to develop novel computational tools that integrate functional genomic data and electronic health records.
Vanderbilt-led team discovers new genetic disease and defines underlying mechanism
Jan. 13, 2020—An international research team has discovered a new genetic syndrome caused by mutation of a single gene and named it CATIFA, an acronym for its core symptoms.
Gamazon receives NIH Genomic Innovator Award
Sep. 19, 2019—VUMC's Eric Gamazon is one of only six investigators to receive an inaugural Genomic Innovator Award from the National Human Genome Research Institute, part of the NIH.
Study merges big data and zebrafish biology to reveal mechanisms of human disease
Apr. 24, 2019—In a series of studies that volleyed between large databases and research in zebrafish, Vanderbilt investigators have discovered a link between vascular biology and eye disease.
Novel genetic study sheds new light on risk of heart attack
Oct. 11, 2018—Loss of a protein that regulates mitochondrial function can greatly increase the risk of myocardial infarction (heart attack), Vanderbilt scientists reported Oct. 3 in the journal eLife.
Vanderbilt study links gene expression, disease association data
Jul. 26, 2018—An international team of researchers has integrated gene expression and disease association data to better understand the biological mechanisms of complex human diseases.
Vanderbilt’s Gamazon named visiting fellow at Cambridge University
Feb. 15, 2018—Eric Gamazon, PhD, research instructor in the Division of Genetic Medicine at Vanderbilt University School of Medicine, is spending part of the academic year at Cambridge University in England as one of 40 Clare Hall Visiting Fellows.
